HEMORGANIC closed yesterday lower at ₹20.94, a decrease of -4.9909% from Friday's close, completing a monthly decrease of -0.8053% or -₹0.17. Over the past 12 months, HEMORGANIC stock gained 24.3468%.
HEMORGANIC is not paying dividends to its shareholders.
The last earnings report, released on May 20, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.